|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.950 EUR | -0.25% |
|
-2.50% | +5.41% |
| 05-05 | MEDICLIN Aktiengesellschaft Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
| 05-04 | MEDICLIN Aktiengesellschaft Revises Earnings Guidance for the Year 2026 | CI |
| Market Cap | 188M 215M 173M 162M 304M 20.24B 311M 2.08B 806M 10B 806M 788M 34.68B | P/E 2026 * |
-
| P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 188M 215M 173M 162M 304M 20.24B 311M 2.08B 806M 10B 806M 788M 34.68B | EV / Sales 2026 * |
0.24x | EV / Sales 2027 * | 0.23x |
| Free-Float |
12.27% | Yield 2026 * |
1.01% | Yield 2027 * | 1.01% |
| 1 day | -0.25% | ||
| 1 week | -2.50% | ||
| Current month | +4.28% | ||
| 1 month | +4.28% | ||
| 3 months | +10.80% | ||
| 6 months | +8.94% | ||
| Current year | +5.41% |
| 1 week | 3.9 |  | 4 |
| 1 month | 3.8 | | 4.26 |
| Current year | 3.22 | | 4.26 |
| 1 year | 2.86 | | 4.26 |
| 3 years | 2.28 | | 4.26 |
| 5 years | 2.28 | | 4.26 |
| 10 years | 2.28 | | 6.88 |
| Manager | Title | Age | Since |
|---|---|---|---|
Tino Marco Fritz
CEO | Chief Executive Officer | 49 | - |
Martin Buse
CMP | Compliance Officer | - | - |
Thomas Piefke
COO | Chief Operating Officer | - | 01/10/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Hans Hilpert
BRD | Director/Board Member | 60 | 01/01/2003 |
Michael Bock
BRD | Director/Board Member | 63 | 25/05/2005 |
| Director/Board Member | 63 | 20/09/2012 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.25% | -2.50% | +30.00% | +27.45% | 215M | |
| -1.76% | -3.79% | +22.87% | +42.28% | 18.46B | |
| +0.95% | +2.49% | +19.85% | +70.25% | 13.1B | |
| -3.38% | -3.26% | -35.48% | -57.78% | 10.93B | |
| +1.61% | +3.37% | -17.08% | +51.58% | 10.05B | |
| -1.62% | +6.12% | +6.33% | +73.38% | 9.45B | |
| +2.72% | +3.28% | -7.35% | -31.89% | 9B | |
| -1.48% | -3.58% | +18.43% | +198.67% | 7.64B | |
| +2.37% | +10.91% | +20.25% | -21.63% | 6.84B | |
| -1.78% | -3.07% | -17.84% | - | 6.81B | |
| Average | -0.26% | +0.96% | +4.00% | +39.14% | 9.25B | |
| Weighted average by Cap. | -0.43% | +0.74% | +3.03% | +39.32% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 787M 898M 726M 680M 1.27B 84.72B 1.3B 8.72B 3.38B 41.87B 3.37B 3.3B 145B | 803M 916M 740M 693M 1.3B 86.42B 1.33B 8.9B 3.44B 42.71B 3.44B 3.36B 148B |
| Net income | 36.66M 41.81M 33.79M 31.64M 59.33M 3.94B 60.56M 406M 157M 1.95B 157M 154M 6.76B | 38.2M 43.56M 35.21M 32.96M 61.81M 4.11B 63.09M 423M 164M 2.03B 164M 160M 7.04B |
| Net Debt | - | - |
Employees
7,416
Calendar
07-30 -
Earnings release - Q2 2026
| Date | Price | Change | Volume |
|---|---|---|---|
| 29/06/26 | €3.900 | -1.52% | 221 |
| 26/06/26 | €3.960 | -1.00% | 1,774 |
| 25/06/26 | €4.000 | +1.01% | 5,858 |
| 24/06/26 | €3.960 | -0.50% | 23,488 |
| 23/06/26 | €3.980 | -0.50% | 408 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
3.960EUR
Average target price
7.300EUR
Spread / Average Target
+84.34%
Net sales - Rate of surprise
- Stock Market
- Stocks
- MED Stock
Select your edition
All financial news and data tailored to specific country editions
